Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Dopamine and reward: the anhedonia hypothesis 30 years on.

Wise RA.

Neurotox Res. 2008 Oct;14(2-3):169-83. doi: 10.1007/BF03033808. Review.

2.
3.

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction.

Di Chiara G.

Behav Brain Res. 2002 Dec 2;137(1-2):75-114. Review.

PMID:
12445717
4.

Differential Dopamine Release Dynamics in the Nucleus Accumbens Core and Shell Reveal Complementary Signals for Error Prediction and Incentive Motivation.

Saddoris MP, Cacciapaglia F, Wightman RM, Carelli RM.

J Neurosci. 2015 Aug 19;35(33):11572-82. doi: 10.1523/JNEUROSCI.2344-15.2015.

5.

The debate over dopamine's role in reward: the case for incentive salience.

Berridge KC.

Psychopharmacology (Berl). 2007 Apr;191(3):391-431. Review.

PMID:
17072591
6.

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis.

Salamone JD, Cousins MS, Snyder BJ.

Neurosci Biobehav Rev. 1997 May;21(3):341-59. Review.

PMID:
9168269
7.

Disentangling pleasure from incentive salience and learning signals in brain reward circuitry.

Smith KS, Berridge KC, Aldridge JW.

Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):E255-64. doi: 10.1073/pnas.1101920108.

8.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84.

PMID:
18097655
9.

Anhedonia, self-experience in schizophrenia, and implications for treatment.

Juckel G, Sass L, Heinz A.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S176-80. Review.

PMID:
14677076
10.
13.

Expected value and prediction error abnormalities in depression and schizophrenia.

Gradin VB, Kumar P, Waiter G, Ahearn T, Stickle C, Milders M, Reid I, Hall J, Steele JD.

Brain. 2011 Jun;134(Pt 6):1751-64. doi: 10.1093/brain/awr059.

14.

The psychology and neurobiology of addiction: an incentive-sensitization view.

Robinson TE, Berridge KC.

Addiction. 2000 Aug;95 Suppl 2:S91-117. Review.

PMID:
11002906
15.

Dopamine, neuroleptics and reinforced behavior.

Ettenberg A.

Neurosci Biobehav Rev. 1989 Summer-Fall;13(2-3):105-11. Review.

PMID:
2573021
16.

Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Salamone JD, Correa M, Farrar A, Mingote SM.

Psychopharmacology (Berl). 2007 Apr;191(3):461-82. Review.

PMID:
17225164
17.

Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.

Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A.

Pharmacopsychiatry. 2001 Mar;34(2):66-72.

PMID:
11302566
18.

Drug addiction as dopamine-dependent associative learning disorder.

Di Chiara G.

Eur J Pharmacol. 1999 Jun 30;375(1-3):13-30. Review.

PMID:
10443561
19.

Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine.

Salamone JD, Correa M, Mingote SM, Weber SM.

Curr Opin Pharmacol. 2005 Feb;5(1):34-41. Review.

PMID:
15661623
20.

Impramine, fluoxetine and clozapine differently affected reactivity to positive and negative stimuli in a model of motivational anhedonia in rats.

Scheggi S, Pelliccia T, Ferrari A, De Montis MG, Gambarana C.

Neuroscience. 2015 Apr 16;291:189-202. doi: 10.1016/j.neuroscience.2015.02.006.

PMID:
25686523
Items per page

Supplemental Content

Support Center